Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial - Conroy, T; Castan, F; Lopez, A (JAMA Oncol, 2022)
et al.